Stubborn inflation at 4.2%, war related supply shocks, and a cautious Federal Reserve under Kevin Warsh are keeping interest rate and bond market risks front and center for U.S. investors. In this kind of cross‑current, many readers are asking which quality value stocks might hold up better if conditions stay bumpy, and which could benefit if policy eventually eases. Using a U.S. Quality Value Stocks screener focused on financially solid large and mid caps, this article highlights 3 stocks that appear positively exposed to the current macro backdrop and explains why they may deserve a closer look.

Atkore (ATKR)

Overview: Atkore is a US-based manufacturer of electrical conduit, cable management, mechanical tubing, and safety products that help protect and power critical infrastructure for customers in construction, industrial, data center, and public sector markets across the United States and internationally.

Operations: Atkore generates about US$2.0b in revenue from its Electrical segment and US$832.7m from Safety & Infrastructure, with the United States contributing roughly US$2.5b of its total revenue base.

Market Cap: US$2.7b

Atkore provides exposure to essential electrical and infrastructure products at a time when tariffs, onshoring, and data center and solar buildouts are supporting demand. Its strong cash generation and low leverage can help cushion higher inflation and interest rates. The stock trades on a lower P/S than many peers. Analysts expect a sharp improvement in earnings and margins over the next few years, supported by recent EBITDA and EPS beats and solid organic volume growth. Against that, revenue has declined over the last two years, free cash flow margins have compressed, and legal settlements around PVC pipe pricing will absorb cash and highlight execution risk just as the business is working to restore long term returns.

Atkore’s cash rich, low leverage profile and lower P/S are only half the story; the real question is whether the current setup still compensates you for execution and legal risks in the 2 key rewards and 2 important warning signs

Ducommun (DCO)

Overview: Ducommun is a US engineering and manufacturing company that supplies complex electronic systems and aerostructure components for commercial and military aircraft, defense programs, and industrial and medical equipment.

Operations: Ducommun generates about US$471.2m in revenue from its Electronic Systems segment and US$370.2m from Structural Systems.

Market Cap: US$2.5b

Ducommun provides focused exposure to aerospace and defense at a time when higher global defense budgets and steady aircraft production support long program cycles. Its interest rate hedge on US$150m of debt helps manage financing costs in a higher rate setting under Kevin Warsh. The stock screens as relatively inexpensive on P/S versus many aerospace and defense peers. However, the company is still working through a history of losses, a fully debt funded liability stack, and questions around backlog quality and margin pressure. For investors who want to understand whether the current valuation and recent earnings momentum balance those risks, the full narrative on Ducommun’s fundamentals and sector positioning provides additional context.

Ducommun’s mix of aerospace and defense programs, combined with a relatively low P/S, suggests investors may be missing something in the current setup. The full full narrative for Ducommun could reveal why that gap exists and what might change it next.

Centene (CNC)

Overview: Centene is a major U.S. managed care company that connects under-insured families and commercial groups to healthcare coverage through Medicaid, Medicare, Marketplace, and specialty services such as behavioral health, dental, and pharmacy benefits.

Operations: Centene generates about US$91.5b from Medicaid, US$38.8b from Medicare, US$41.4b from Commercial plans, and US$5.0b from Other and eliminations, almost entirely from the United States.

Market Cap: US$31.3b

Centene appears in this quality value screener because it combines a defensive health insurance footprint with a valuation that is low on a price-to-sales basis relative to U.S. healthcare peers, alongside a narrative of margin recovery at a time when higher inflation and a cautious Federal Reserve keep rate and credit risks elevated. Analysts widely discuss Medicaid and Medicare margins, Marketplace membership trends, and a raised 2026 revenue and EPS outlook. At the same time, the company remains loss making and operates with a funding structure that carries higher risk. Recent cost cutting initiatives, changes to the board and leadership team, and ongoing community investments together create a setup that offers a mix of potential upside and execution risk that may warrant closer attention from investors.

Centene’s push for margin recovery, combined with a low P/S and a still loss making profile, makes the real question what the market might be missing in the analysis report for Centene

The three stocks in this article are just a starting point, and the full U.S. Quality Value Stocks screener surfaces 11 more large and mid cap U.S. companies with similarly compelling quality and value stories that you have not seen yet. Use Simply Wall St to identify and analyze the exact catalysts, financial traits, and narratives that matter to you so you can focus on the highest conviction ideas in this quality value theme.

Take Control of Your Investment Journey

If Centene or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

Fresh opportunities can move quickly, and the most attractive entry points often appear before the crowd catches on. Identify potential breakout stories while it matters, then decide how you want to respond.

• Explore potential under-the-radar momentum by scanning a curated group of small companies in the 23 elite penny stocks with strong financials before interest and pricing move away from you.
• Review possible tech adoption stories by considering businesses in the 34 AI small caps while many investors are still focused on the rear view mirror.
• Focus on resilient balance sheets and disciplined cash generation using the carefully filtered list of solid balance sheet and fundamentals (48 results) so you are less exposed to weaker stocks if conditions change.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.